InDex Pharmaceuticals Holding AB (publ) Share Price Nasdaq Stockholm
Equities
SE0008966295
Pharmaceuticals
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 196M 2.14B 16.34B |
---|---|---|---|---|---|
Net income 2024 * | -259M -2.83B -21.59B | Net income 2025 * | -221M -2.42B -18.43B | EV / Sales 2024 * | - |
Net Debt 2024 * | 86.32M 944M 7.2B | Net Debt 2025 * | 306M 3.35B 25.5B | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.75
x | P/E ratio 2025 * |
-0.9
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 62.47% |
Managers | Title | Age | Since |
---|---|---|---|
Jenny Sundqvist
CEO | Chief Executive Officer | 53 | 01/23/01 |
Johan Gileus
DFI | Director of Finance/CFO | 59 | 01/17/01 |
Charlotte Admyre
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Uli Alf Hacksell
BRD | Director/Board Member | 74 | 01/16/01 |
Director/Board Member | 68 | 01/11/01 | |
Chairman | 72 | 01/11/01 |
1st Jan change | Capi. | |
---|---|---|
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |